Widespread Use of GLP-1 Drugs Revealed in U.S. Survey

One in eight American adults has used medications like Ozempic for weight loss or chronic conditions, highlighting a surge in demand and concerns over affordability.

Survey finds 12% of U.S. adults have used GLP-1 drugs, with significant usage among diabetics and heart disease patients.
High cost remains a barrier, with over half of users reporting difficulties in affording these medications.
Medicare coverage debated as majority supports inclusion for weight loss prescriptions amid regulatory restrictions.
Drug shortages persist as manufacturers struggle to meet the high demand for popular GLP-1 drugs like Wegovy.
Public awareness of GLP-1 medications has increased, with many seeking them for both approved and off-label uses.